Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-109128

Dolby Laboratories, Inc. · DLB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Dagmar Dolby
10% Owner
Period of report
Mar 15, 2016
Accepted (ET)
Mar 17, 2016 · 4:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001308547

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A Common StockF1,F2Mar 15, 2016C25,000$0.00A25,000IBy Trust
Class A Common StockF3,F2Mar 15, 2016S25,000$40.0029D0IBy Trust
Class A Common StockF1,F4Mar 15, 2016C25,000$0.00A25,000IBy Trust
Class A Common StockF3,F4Mar 15, 2016S25,000$40.004D0IBy Trust
Class A Common StockF1,F2Mar 16, 2016C25,000$0.00A25,000IBy Trust
Class A Common StockF5,F2Mar 16, 2016S25,000$40.0212D0IBy Trust
Class A Common StockF1,F4Mar 16, 2016C25,000$0.00A25,000IBy Trust
Class A Common StockF5,F4Mar 16, 2016S25,000$40.022D0IBy Trust
Class A Common StockF6holding———100IBy Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Class B Common StockF2,F7—Mar 15, 2016C25,000D——Class A Common Stock25,000674,436I
Class B Common StockF4,F7—Mar 15, 2016C25,000D——Class A Common Stock25,0001,075,283I
Class B Common StockF2,F7—Mar 16, 2016C25,000D——Class A Common Stock25,000649,436I
Class B Common StockF4,F7—Mar 16, 2016C25,000D——Class A Common Stock25,0001,050,283I
Class B Common StockF8,F7—holding—————Class A Common Stock—23,674,496I
Class B Common StockF9,F7—holding—————Class A Common Stock—13,005,294I
Class B Common StockF10,F7—holding—————Class A Common Stock—925,450I
Class B Common StockF11,F7—holding—————Class A Common Stock—925,450I
Class B Common StockF12,F7—holding—————Class A Common Stock—2,500,000I
Class B Common StockF13,F7—holding—————Class A Common Stock—2,103,495I
Class B Common StockF14,F7—holding—————Class A Common Stock—2,103,171I

Explanation of responses

Remarks

**All of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.**